KURA ONCOLOGY Trademark

Trademark Overview

On Friday, June 2, 2023, a trademark application was filed for KURA ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the KURA ONCOLOGY trademark a serial number of 98024676. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 28, 2025. This trademark is owned by Kura Oncology, Inc.. The KURA ONCOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer
kura oncology

General Information

Serial Number98024676
Word MarkKURA ONCOLOGY
Filing DateFriday, June 2, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of cancer
NOT AVAILABLEONCOLOGY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 6, 2023
Primary Code005
First Use Anywhere DateFriday, December 29, 2023
First Use In Commerce DateFriday, December 29, 2023

Trademark Owner History

Party NameKura Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameKura Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Tuesday, June 6, 2023NEW APPLICATION ENTERED
Thursday, July 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 2, 2024TEAS AMENDMENT OF USE RECEIVED
Saturday, February 3, 2024USE AMENDMENT FILED
Saturday, February 3, 2024AMENDMENT TO USE PROCESSING COMPLETE
Monday, February 26, 2024ASSIGNED TO EXAMINER
Monday, February 26, 2024NON-FINAL ACTION WRITTEN
Monday, February 26, 2024NON-FINAL ACTION E-MAILED
Monday, February 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 27, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, March 27, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, May 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 8, 2024USE AMENDMENT ACCEPTED
Thursday, July 11, 2024FINAL REFUSAL E-MAILED
Thursday, July 11, 2024FINAL REFUSAL WRITTEN
Thursday, July 11, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 12, 2024SUSPENSION LETTER WRITTEN
Friday, July 12, 2024LETTER OF SUSPENSION E-MAILED
Friday, July 12, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 6, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

oncology kura cancer treatment products pharmaceutical